A U.S. humanitarian waiver will allow people in several countries to continue accessing life-saving HIV treatments, the UNAIDS said on Wednesday, after President Donald Trump's freeze on foreign aid threatened such supplies.

The Trump administration has made some concessions to the halt placed on distributions of global HIV treatments via the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), according to The New York Times.

The Trump administration has moved to stop the supply of lifesaving drugs for HIV, malaria, and tuberculosis in countries supported by USAID around the globe.

As part of the foreign aid freeze by President Donald Trump, the U.S. distribution of HIV drugs in poor countries has been stopped.

Almost 1 in 10 patients receiving HIV care may have binge eating disorder (BED), a significantly higher rate than the 0.3% reported in the general population, according to a cross-sectional study. Individuals with possible BED were six times more likely than others to have clinical obesity and twice as likely to be overweight.

Almost 136,000 babies are expected to be born with HIV in the next three months, mostly in Africa, because of the Trump administration’s “stop work order” on foreign assistance, according to a top research foundation.

In patients with HIV, alcohol reduction after a 6-month intervention and adherence to isoniazid had no effect on the high levels of viral suppression reported at baseline.

Major barriers in screening for fatty liver disease in patients with HIV included uncertainties about testing, diagnostic data insufficiency, low priority, time constraints, and referral limitations.

The Trump administration has moved to stop the supply of lifesaving drugs for HIV, malaria and tuberculosis, as well as medical supplies for newborn babies, in countries supported by USAID around the globe.

The United States Secretary of State's "Emergency Humanitarian Waiver" will allow people to continue accessing life-saving HIV treatment, UNAIDS said on Wednesday. UNAIDS is a joint venture of the United Nations,

The Donald Trump administration has stopped a program that distributes an anti-HIV drug in poor countries.